Skip to main navigation
logo

Investor Relations

  • Archived Advaxis News Releases
  • Archived Advaxis Events & Presentations
  • Archived Advaxis Quarterly Results

Events and Presentations

Events and Presentations

Presentations

Sep 14, 2022
Corporate Presentation - September 2022
Oct 28, 2021
Gutierrez AA. Clinical activity and immunogenicity of a neoantigen immunotherapy in non-small cell lung cancer. Neoantigen Based Therapies Summit. Weaponizing Vaccines and Cell Based Immunotherapies. October 28, 2021. Virtual Meeting
Jul 15, 2021
Gutierrez AA. Can neoantigen immunotherapies reverse resistance to PD-1 inhibitors and progression in NSCLC?. Non-Small Cell Lung Cancer Drug Development Summit. Virtual meeting. July 15, 2021
Feb 27, 2020
IO 360 Presentation
Feb 06, 2019
Immuno-Oncology 360° Conference Presentation

Upcoming Events

More events are coming soon.

Past Events

Jul 6, 2021 at 8:30 AM EDT
Advaxis Corporate Update Call
Mar 24, 2021 at 2:30 PM EDT
Benzinga Biotech Small Cap Conference
Sep 2, 2020 at 3:40 PM EDT
LD Micro 500 Virtual Conference
Jun 11, 2020 at 11:00 AM EDT
Advaxis, Inc. Second Quarter 2020 Earnings Call
May 4, 2020 at 10:00 AM EDT
2020 Annual Stockholders’ Meeting
Mar 4, 2020 at 11:00 AM PST
2020 LD Virtual
Feb 26 from 11:00 AM EST to Feb 28, 2020
Immuno-oncology 360°
Feb 19 from 7:00 AM PST to Feb 21, 2020
IASLC 2020 Targeted Therapies of Lung Cancer Meeting
Feb 12 from 11:30 AM PST to Feb 14, 2020
ASCO - Genitourinary Cancers Symposium
Jun 11, 2019 at 11:00 AM EDT
Advaxis, Inc. Business Update Conference Call

Pagination

  • Current page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page next ›
  • Last page last »

© 2023 Advaxis, Inc..     All rights reserved.

  • Facebook
  • Twitter
  • LinkedIn
  • Google+